Activity Description:

This session will review the indications for NICU referral for patent ductus arteriosus (PDA) closure in the cardiac catheterization laboratory. The discussion will emphasize the importance of a multidisciplinary approach in ensuring program success. Key aspects of care from the cardiac catheterization perspective will be highlighted, including criteria for referral, coordination and transfers of care between the NICU and the cath lab, and strategies to maintain patient safety throughout and after the procedure.

Target Audience: 

This course is designed for Physicians, Advanced Practice Providers, Nurses, and Allied Health Professionals involved in pediatric and adult congenital heart care.

Learning Objectives:

• Differentiate clinical and echocardiographic criteria that support referral for transcatheter PDA closure versus continued medical management in preterm infants.
• Describe the multidisciplinary framework, institutional resources, patient selection processes, and quality metrics necessary to establish and sustain an preterm PDA closure program.
• Discuss best practices for post-procedural NICU care following PDA closure to ensure optimal neonatal safety and recovery.

Congenital Heart Disease Grand Rounds March 2026 Bridging NICU and Cath Lab(2).pdf

Moderator:

Melody Turner, MSN, MBA, RN, AVP

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and HCA Healthcare. The HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. None of the planners, faculty, and those in control of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.